• レポートコード:QYR2104Z0080 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、126ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品、ヘルスケア |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、急性副鼻腔炎のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(OTC鎮痛剤、生理食塩水点鼻薬、鼻コルチコステロイド、その他)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・急性副鼻腔炎の市場動向 ・企業の競争状況、市場シェア ・急性副鼻腔炎の種類別市場規模(OTC鎮痛剤、生理食塩水点鼻薬、鼻コルチコステロイド、その他) ・急性副鼻腔炎の用途別市場規模(病院、クリニック) ・急性副鼻腔炎の北米市場規模2016-2027(アメリカ、カナダ) ・急性副鼻腔炎のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・急性副鼻腔炎のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・急性副鼻腔炎の中南米市場規模2016-2027(メキシコ、ブラジル) ・急性副鼻腔炎の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Teva Pharmaceutical、Sun Pharmaceutical、Sanofi、Pfizer、Novartis、Merck、Johnson & Johnson、Fresenius Kabi、Eli Lilly and Company、Dr. Reddy's Laboratories、Bristol-Myers Squibb、Bionorica、Bayer、AstraZeneca、Amgen、Abbott) ・結論 |
Acute sinusitis, also called acute rhinosinusitis, is a short-term inflammation of the membranes that line your nose and surrounding sinuses.
Market Analysis and Insights: Global Acute Sinusitis Market
The global Acute Sinusitis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Sinusitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Sinusitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Sinusitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Sinusitis market.
Global Acute Sinusitis Scope and Market Size
Acute Sinusitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Sinusitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
OTC Pain Relievers
Saline Nasal Spray
Nasal Corticosteroids
Others
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Teva Pharmaceutical
Sun Pharmaceutical
Sanofi
Pfizer
Novartis
Merck
Johnson & Johnson
Fresenius Kabi
Eli Lilly and Company
Dr. Reddy’s Laboratories
Bristol-Myers Squibb
Bionorica
Bayer
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Sinusitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC Pain Relievers
1.2.3 Saline Nasal Spray
1.2.4 Nasal Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Sinusitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Sinusitis Market Perspective (2016-2027)
2.2 Acute Sinusitis Growth Trends by Regions
2.2.1 Acute Sinusitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Sinusitis Historic Market Share by Regions (2016-2021)
2.2.3 Acute Sinusitis Forecasted Market Size by Regions (2022-2027)
2.3 Acute Sinusitis Industry Dynamic
2.3.1 Acute Sinusitis Market Trends
2.3.2 Acute Sinusitis Market Drivers
2.3.3 Acute Sinusitis Market Challenges
2.3.4 Acute Sinusitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Sinusitis Players by Revenue
3.1.1 Global Top Acute Sinusitis Players by Revenue (2016-2021)
3.1.2 Global Acute Sinusitis Revenue Market Share by Players (2016-2021)
3.2 Global Acute Sinusitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Sinusitis Revenue
3.4 Global Acute Sinusitis Market Concentration Ratio
3.4.1 Global Acute Sinusitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Sinusitis Revenue in 2020
3.5 Acute Sinusitis Key Players Head office and Area Served
3.6 Key Players Acute Sinusitis Product Solution and Service
3.7 Date of Enter into Acute Sinusitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Sinusitis Breakdown Data by Type
4.1 Global Acute Sinusitis Historic Market Size by Type (2016-2021)
4.2 Global Acute Sinusitis Forecasted Market Size by Type (2022-2027)
5 Acute Sinusitis Breakdown Data by Application
5.1 Global Acute Sinusitis Historic Market Size by Application (2016-2021)
5.2 Global Acute Sinusitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Sinusitis Market Size (2016-2027)
6.2 North America Acute Sinusitis Market Size by Type
6.2.1 North America Acute Sinusitis Market Size by Type (2016-2021)
6.2.2 North America Acute Sinusitis Market Size by Type (2022-2027)
6.2.3 North America Acute Sinusitis Market Size by Type (2016-2027)
6.3 North America Acute Sinusitis Market Size by Application
6.3.1 North America Acute Sinusitis Market Size by Application (2016-2021)
6.3.2 North America Acute Sinusitis Market Size by Application (2022-2027)
6.3.3 North America Acute Sinusitis Market Size by Application (2016-2027)
6.4 North America Acute Sinusitis Market Size by Country
6.4.1 North America Acute Sinusitis Market Size by Country (2016-2021)
6.4.2 North America Acute Sinusitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acute Sinusitis Market Size (2016-2027)
7.2 Europe Acute Sinusitis Market Size by Type
7.2.1 Europe Acute Sinusitis Market Size by Type (2016-2021)
7.2.2 Europe Acute Sinusitis Market Size by Type (2022-2027)
7.2.3 Europe Acute Sinusitis Market Size by Type (2016-2027)
7.3 Europe Acute Sinusitis Market Size by Application
7.3.1 Europe Acute Sinusitis Market Size by Application (2016-2021)
7.3.2 Europe Acute Sinusitis Market Size by Application (2022-2027)
7.3.3 Europe Acute Sinusitis Market Size by Application (2016-2027)
7.4 Europe Acute Sinusitis Market Size by Country
7.4.1 Europe Acute Sinusitis Market Size by Country (2016-2021)
7.4.2 Europe Acute Sinusitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Sinusitis Market Size (2016-2027)
8.2 Asia-Pacific Acute Sinusitis Market Size by Type
8.2.1 Asia-Pacific Acute Sinusitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Sinusitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Sinusitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Sinusitis Market Size by Application
8.3.1 Asia-Pacific Acute Sinusitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Sinusitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Sinusitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Sinusitis Market Size by Region
8.4.1 Asia-Pacific Acute Sinusitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Sinusitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Sinusitis Market Size (2016-2027)
9.2 Latin America Acute Sinusitis Market Size by Type
9.2.1 Latin America Acute Sinusitis Market Size by Type (2016-2021)
9.2.2 Latin America Acute Sinusitis Market Size by Type (2022-2027)
9.2.3 Latin America Acute Sinusitis Market Size by Type (2016-2027)
9.3 Latin America Acute Sinusitis Market Size by Application
9.3.1 Latin America Acute Sinusitis Market Size by Application (2016-2021)
9.3.2 Latin America Acute Sinusitis Market Size by Application (2022-2027)
9.3.3 Latin America Acute Sinusitis Market Size by Application (2016-2027)
9.4 Latin America Acute Sinusitis Market Size by Country
9.4.1 Latin America Acute Sinusitis Market Size by Country (2016-2021)
9.4.2 Latin America Acute Sinusitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Sinusitis Market Size (2016-2027)
10.2 Middle East & Africa Acute Sinusitis Market Size by Type
10.2.1 Middle East & Africa Acute Sinusitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Sinusitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Sinusitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Sinusitis Market Size by Application
10.3.1 Middle East & Africa Acute Sinusitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Sinusitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Sinusitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Sinusitis Market Size by Country
10.4.1 Middle East & Africa Acute Sinusitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Sinusitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Acute Sinusitis Introduction
11.1.4 Teva Pharmaceutical Revenue in Acute Sinusitis Business (2016-2021)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Details
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Acute Sinusitis Introduction
11.2.4 Sun Pharmaceutical Revenue in Acute Sinusitis Business (2016-2021)
11.2.5 Sun Pharmaceutical Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Acute Sinusitis Introduction
11.3.4 Sanofi Revenue in Acute Sinusitis Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Acute Sinusitis Introduction
11.4.4 Pfizer Revenue in Acute Sinusitis Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Acute Sinusitis Introduction
11.5.4 Novartis Revenue in Acute Sinusitis Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Acute Sinusitis Introduction
11.6.4 Merck Revenue in Acute Sinusitis Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Acute Sinusitis Introduction
11.7.4 Johnson & Johnson Revenue in Acute Sinusitis Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Details
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Acute Sinusitis Introduction
11.8.4 Fresenius Kabi Revenue in Acute Sinusitis Business (2016-2021)
11.8.5 Fresenius Kabi Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Acute Sinusitis Introduction
11.9.4 Eli Lilly and Company Revenue in Acute Sinusitis Business (2016-2021)
11.9.5 Eli Lilly and Company Recent Development
11.10 Dr. Reddy’s Laboratories
11.10.1 Dr. Reddy’s Laboratories Company Details
11.10.2 Dr. Reddy’s Laboratories Business Overview
11.10.3 Dr. Reddy’s Laboratories Acute Sinusitis Introduction
11.10.4 Dr. Reddy’s Laboratories Revenue in Acute Sinusitis Business (2016-2021)
11.10.5 Dr. Reddy’s Laboratories Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Acute Sinusitis Introduction
11.11.4 Bristol-Myers Squibb Revenue in Acute Sinusitis Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Bionorica
11.12.1 Bionorica Company Details
11.12.2 Bionorica Business Overview
11.12.3 Bionorica Acute Sinusitis Introduction
11.12.4 Bionorica Revenue in Acute Sinusitis Business (2016-2021)
11.12.5 Bionorica Recent Development
11.13 Bayer
11.13.1 Bayer Company Details
11.13.2 Bayer Business Overview
11.13.3 Bayer Acute Sinusitis Introduction
11.13.4 Bayer Revenue in Acute Sinusitis Business (2016-2021)
11.13.5 Bayer Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Acute Sinusitis Introduction
11.14.4 AstraZeneca Revenue in Acute Sinusitis Business (2016-2021)
11.14.5 AstraZeneca Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Acute Sinusitis Introduction
11.15.4 Amgen Revenue in Acute Sinusitis Business (2016-2021)
11.15.5 Amgen Recent Development
11.16 Abbott
11.16.1 Abbott Company Details
11.16.2 Abbott Business Overview
11.16.3 Abbott Acute Sinusitis Introduction
11.16.4 Abbott Revenue in Acute Sinusitis Business (2016-2021)
11.16.5 Abbott Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acute Sinusitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC Pain Relievers
Table 3. Key Players of Saline Nasal Spray
Table 4. Key Players of Nasal Corticosteroids
Table 5. Key Players of Others
Table 6. Global Acute Sinusitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Sinusitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Sinusitis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Sinusitis Market Share by Regions (2016-2021)
Table 10. Global Acute Sinusitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Sinusitis Market Share by Regions (2022-2027)
Table 12. Acute Sinusitis Market Trends
Table 13. Acute Sinusitis Market Drivers
Table 14. Acute Sinusitis Market Challenges
Table 15. Acute Sinusitis Market Restraints
Table 16. Global Acute Sinusitis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Sinusitis Market Share by Players (2016-2021)
Table 18. Global Top Acute Sinusitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Sinusitis as of 2020)
Table 19. Ranking of Global Top Acute Sinusitis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Sinusitis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Sinusitis Product Solution and Service
Table 23. Date of Enter into Acute Sinusitis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Sinusitis Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Sinusitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Sinusitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Sinusitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Sinusitis Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Sinusitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Sinusitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Sinusitis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Sinusitis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Sinusitis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Sinusitis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Sinusitis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Sinusitis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Sinusitis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Sinusitis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Sinusitis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Sinusitis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Sinusitis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Sinusitis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Sinusitis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Sinusitis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Sinusitis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Sinusitis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Sinusitis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Sinusitis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Sinusitis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Sinusitis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Sinusitis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Sinusitis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Sinusitis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Sinusitis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Sinusitis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Sinusitis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Teva Pharmaceutical Company Details
Table 64. Teva Pharmaceutical Business Overview
Table 65. Teva Pharmaceutical Acute Sinusitis Product
Table 66. Teva Pharmaceutical Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 67. Teva Pharmaceutical Recent Development
Table 68. Sun Pharmaceutical Company Details
Table 69. Sun Pharmaceutical Business Overview
Table 70. Sun Pharmaceutical Acute Sinusitis Product
Table 71. Sun Pharmaceutical Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 72. Sun Pharmaceutical Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Acute Sinusitis Product
Table 76. Sanofi Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Acute Sinusitis Product
Table 81. Pfizer Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Acute Sinusitis Product
Table 86. Novartis Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Acute Sinusitis Product
Table 91. Merck Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Acute Sinusitis Product
Table 96. Johnson & Johnson Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. Fresenius Kabi Company Details
Table 99. Fresenius Kabi Business Overview
Table 100. Fresenius Kabi Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 101. Fresenius Kabi Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Acute Sinusitis Product
Table 105. Eli Lilly and Company Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. Dr. Reddy's Laboratories Company Details
Table 108. Dr. Reddy's Laboratories Business Overview
Table 109. Dr. Reddy's Laboratories Acute Sinusitis Product
Table 110. Dr. Reddy's Laboratories Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 111. Dr. Reddy's Laboratories Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Acute Sinusitis Product
Table 115. Bristol-Myers Squibb Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Bionorica Company Details
Table 118. Bionorica Business Overview
Table 119. Bionorica Acute Sinusitis Product
Table 120. Bionorica Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 121. Bionorica Recent Development
Table 122. Bayer Company Details
Table 123. Bayer Business Overview
Table 124. Bayer Acute Sinusitis Product
Table 125. Bayer Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 126. Bayer Recent Development
Table 127. AstraZeneca Company Details
Table 128. AstraZeneca Business Overview
Table 129. AstraZeneca Acute Sinusitis Product
Table 130. AstraZeneca Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 131. AstraZeneca Recent Development
Table 132. Amgen Company Details
Table 133. Amgen Business Overview
Table 134. Amgen Acute Sinusitis Product
Table 135. Amgen Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 136. Amgen Recent Development
Table 137. Abbott Company Details
Table 138. Abbott Business Overview
Table 139. Abbott Acute Sinusitis Product
Table 140. Abbott Revenue in Acute Sinusitis Business (2016-2021) & (US$ Million)
Table 141. Abbott Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Sinusitis Market Share by Type: 2020 VS 2027
Figure 2. OTC Pain Relievers Features
Figure 3. Saline Nasal Spray Features
Figure 4. Nasal Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Acute Sinusitis Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Acute Sinusitis Report Years Considered
Figure 10. Global Acute Sinusitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Sinusitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Sinusitis Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Sinusitis Market Share by Regions (2022-2027)
Figure 14. Global Acute Sinusitis Market Share by Players in 2020
Figure 15. Global Top Acute Sinusitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Sinusitis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Sinusitis Revenue in 2020
Figure 17. Global Acute Sinusitis Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Sinusitis Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Sinusitis Market Share by Type (2016-2027)
Figure 21. North America Acute Sinusitis Market Share by Application (2016-2027)
Figure 22. North America Acute Sinusitis Market Share by Country (2016-2027)
Figure 23. United States Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Sinusitis Market Share by Type (2016-2027)
Figure 27. Europe Acute Sinusitis Market Share by Application (2016-2027)
Figure 28. Europe Acute Sinusitis Market Share by Country (2016-2027)
Figure 29. Germany Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Sinusitis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Sinusitis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Sinusitis Market Share by Region (2016-2027)
Figure 39. China Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Sinusitis Market Share by Type (2016-2027)
Figure 47. Latin America Acute Sinusitis Market Share by Application (2016-2027)
Figure 48. Latin America Acute Sinusitis Market Share by Country (2016-2027)
Figure 49. Mexico Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Sinusitis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Sinusitis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Sinusitis Market Share by Country (2016-2027)
Figure 55. Turkey Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Sinusitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Teva Pharmaceutical Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 59. Sun Pharmaceutical Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 65. Fresenius Kabi Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 67. Dr. Reddy's Laboratories Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 69. Bionorica Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 70. Bayer Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 73. Abbott Revenue Growth Rate in Acute Sinusitis Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed